Skip to content
healthcare.dev

AFSTYLA Antihemophilic Factor (Recombinant), Single Chain

NDC 69911-476, ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT, kit, from CSL Behring Lengnau AG.

Product NDC
69911-476
Status
Listed
Labeler
CSL Behring Lengnau AG
Dosage form
KIT
Route
—
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125591
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69911-476 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
69911-476-02699110476021 KIT in 1 CARTON (69911-476-02) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-486-01) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-765-83)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69911-476

Use it

Look up 69911-476 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69911-476 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69911-476. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.